Anti-Factor H Antibodies; anti-CFH; Complement Factor H Ab
Factor H Antibodies, Plasma
Test
Aliases/Synonyms
Method
ELISA
Report Includes
Factor H Antibodies
Specimens
Plasma
Clinical Utility
Atypical hemolytic uremic syndrome (aHUS) is an inherited or acquired thrombotic microangiopathy (TMA) caused by dysregulated activation of the alternate pathway of the complement system.Factor H (FH) negatively regulates the alternate complement pathway.A loss of FH function by mutation or under the action of an inhibitor (auto-antibody) is associated with the onset of aHUS.The anti-FH antibody assay by ELISA confirms or invalidates a diagnosis of acquired aHUS due to the presence of anti-FH antibodies.
Test Location
QC, CA
Test Version
15-Dec-2022
Specimen
Specimens
Plasma
Collection Containers
Blue top (3.2% buffered citrate)
Sample Volume
2 mL
Minimum Volume
2 mL
Collection & Handling
Handling Information
Prepare platelet-poor plasma and freeze immediately. Store and send frozen.
Stability
Frozen | Frozen |
---|
Rejection Criteria
Specimen | Serum |
---|
Test Version
15-Dec-2022
Performance / Interpretation
Method
ELISA
Turnaround Time
1 month
Results
Name | Units | Reference Range | Conversion Factor | |
---|---|---|---|---|
Factor H Antibodies | Titer |
|
||
Test Location
QC, CA
Test Version
15-Dec-2022
Interface / Setup
HL7 Interface Codes
Order Code | Result Codes | Units |
---|---|---|
AFHA P | 64717Anti-Factor H | titre |
Test Version
15-Dec-2022